Market Tracker

07/31 9:08am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.54
Delayed Data
As of Jul 30
 -0.13 / -4.87%
Today’s Change
2.50
Today|||52-Week Range
7.50
-26.80%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.67
Today’s open2.64
Day’s range2.54 - 2.68
Volume50,605
Average volume (3 months)170,524
Market cap$60.3M
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-15.38%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.74

Competitors

 Today’s
change
Today’s
% change
GBSNUGreat Basin Scientif...+0.02+0.12%
ERBERBA Diagnostics Inc-0.08-4.21%
TROVUTrovagene Inc0.000.00%
TTHITransition Therapeut...-0.06-2.68%
Data as of 07/30/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts